Low-dose difluoromethylornithine and polyamine levels in human prostate tissue

Journal of the National Cancer Institute

Volumn 91, Issue 16, 1999, Pages 1416-1417

  Messing, Edward M ^b   Love, Richard R ^a,b   Tutsch, Kendra D ^a   Verma, Ajit K ^a   Douglas, Jeffrey ^a   Pomplun, Marcia ^a   Simsiman, Ruby ^a   Wilding, George ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b School of Medicine ^*

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; CREATININE; EFLORNITHINE; ORNITHINE DECARBOXYLASE; POLYAMINE; PROSTATE SPECIFIC ANTIGEN; PUTRESCINE; SPERMIDINE; SPERMINE; TESTOSTERONE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; MALE; ORAL DRUG ADMINISTRATION; POLYAMINE SYNTHESIS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL; SKIN BIOPSY; TESTOSTERONE BLOOD LEVEL;

EID: 0033581178     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/91.16.1416     Document Type: Article

References (20)

1. Boutwell RK. Some biological aspects of skin carcinogenesis. Prog Exp Tumor Res 1964;4:207-50.
2. Boutwell RK, Verma AK, Ashendel CL, Astrup E. Mouse skin: a useful model system for studying the mechanism of chemical carcinogenesis. In: Hecker E, Fusenig NE, Kunz W, Marks F, Theilmann H, editors. Carcinogenesis - a comprehensive survey. New York (NY): Raven Press; 1982. p. 1-12.
3. Messing EM, Reznikoff CA. Normal and malignant urothelium: in vitro effects of epidermal growth factor. Cancer Res 1987;47: 2230-5.
4. Messing EM, Hanson P, Reznikoff CA. Normal and malignant human urothelium: in vitro response to blockade of polyamine synthesis and interconversion. Cancer Res 1988; 48:357-61.
5. Fjosne HE, Strand H, Ostensen MA, Sunde A. Ornithine decarboxylase and S-adenosylmethionine decarboxylase activity in the accessory sex organs of intact, castrated, and androgen-stimulated castrated rats. Prostate 1988;12:309-20.
6. Fjosne HE, Ostensen MA, Haarstad H, Sunde A. Androgen regulation of polyamine synthesis in seminal vesicle and in different lobes of the rat prostate. Prostate 1990;17: 1-11.
7. Rui H, Purvis K. Prolactin selectively stimulates ornithine decarboxylase in the lateral lobe of the rat prostate. Mol Cell Endocrinol 1987;50:89-97.
8. Fozard JR, Prakash NJ. Effects of DL-α-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, on the rat mammary tumor induced by 7,12-dimethylbenz[a]anthracene. Naunyn Schmiedebergs Arch Pharmacol 1982;320: 72-7.
9. Tutton PJ, Barkla DH. Comparison of the effects of an ornithine decarboxylase inhibitor on the intestinal epithelium and on intestinal tumors. Cancer Res 1986;46(12 Pt 1): 6091-4.
10. Takigawa M, Verma AK, Simsiman RC, Boutwell RK. Inhibition of mouse skin tumor promotion and of promoter-stimulated epidermal polyamine biosynthesis by alpha-difluoromethylornithine. Cancer Res 1983; 43:3732-8.
11. Homma Y, Kakizoe T, Samma S, Oyasu R. Inhibition of N-butyl-JV-(4-hydroxybutyl)nitrosamine-induced rat urinary bladder carcinogenesis by alpha-difluoromethylornithine. Cancer Res 1987;47:6176-9.
12. Love RR, Carbone PP, Verma AK, Gilmore D, Carey P, Tutsch KD, et al. Randomized phase I chemoprevention dose-seeking study of alpha-difluoromethylornithine. J Natl Cancer Inst 1993;85:732-7.
13. Love RR, Jacoby R, Newton MA, Tutsch KD, Simon K, Pomplun M, et al. A randomized, placebo-controlled trial of low-dose α-difluoromethylornithine in individuals at risk for colorectal cancer. Cancer Epidemiol Biomarkers Prev 1998;7:989-92.
14. Meyskens FL Jr, Gerner EW, Emerson S, Pelot D, Durbin T, Doyle K, et al. Effect of α-difluoromethylornithine on rectal mucosal levels of polyamines in a randomized, double-blinded trial for colon cancer prevention. J Natl Cancer Inst 1998;90:1212-8.
15. Heston WD. Prostatic polyamines and polyamine targeting as a new approach to therapy of prostatic cancer. Cancer Surv 1991;11: 217-38.
16. Heston WD, Kadmon D, Lazan DW, Fair WR. Copenhagen rat prostatic tumor ornithine decarboxylase activity (ODC) and the effect of ODC inhibitor α-difluoromethylornithine. Prostate 1982;3:383-9.
17. Loprinzi CL, Love RR, Therneau TM, Verma AK. Inhibition of human skin ornithine decarboxylase activity by oral alpha-difluoromethylonithine. Cancer Therapy Control 1989;1:75-80.
18. Pegg AE. Recent advances in the biochemistry of polyamines in eukaryotes. Biochem J 1986;234:249-62.
19. Pegg AE. Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy. Cancer Res 1988;48:759-74.
20. Knapp DW, Richardson RC, Chan TC, Bottoms GD, Widmer WR, DeNicola DB, et al. Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder. J Vet Intern Med 1994;8:273-8.